corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library

Items published during the years 2000 to 2009

There are 14385 items in the Healthy Skepticism Library that were published during the years 2000 to 2009.

Page 52 of 144 pages ‹ First  < 50 51 52 53 54 >  Last ›

HSL11899
Vladeck DC.
The Difficult Case of Direct-to-Consumer Drug Advertising
41 Loyola Los Angeles Law Review (forthcoming 2008) 2007 Sep 3;
http://lsr.nellco.org/cgi/viewcontent.cgi?article=1002&context=georgetown/ois

HSL12154
Kucinich D.
Get rid of the for-profits: Healthcare can no longer be a commodity for sale to those who can afford it
Mod Healthc 2007 Sep 3; 37:(35):40
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17957898

HSL11397
Policing pharma
Financial Times 2007 Sep 2
http://www.ft.com/cms/s/5c8fdc2a-5985-11dc-aef5-0000779fd2ac,Authorised=false.html?_i_location=http%3A%2F%2Fwww.ft.com%2Fcms%2Fs%2F5c8fdc2a-5985-11dc-aef5-0000779fd2ac.html&_i_referer=http%3A%2F%2Fwww.google.com.au%2Fsearch%3Fsourceid%3Dnavclient

HSL11350
Butcher J.
The story of fenoterol
The Lancet 2007 Sep 1; 370:(9589):732
http://www.thelancet.com/journals/lancet/article/PIIS0140673607613610/fulltext

HSL11351
Smith R.
Should we loosen the grip on drug companies?
BMJ 2007 Sep 1; 335:(7617):454
http://www.bmj.com/cgi/content/short/335/7617/454?etoc

HSL11318
Jones SC, Lynch M.
Non-advertising alcohol promotions in licensed premises: does the Code of Practice ensure responsible promotion of alcohol?
Drug Alcohol Rev 2007 Sep; 26:(5):477-85
http://www.informaworld.com/smpp/content?content=10.1080/09595230701494390

HSL11396
Moreno C, Laje G, Blanco C, Jiang H, Schmidt AB, Olfson M
National Trends in the Outpatient Diagnosis and Treatment of Bipolar Disorder in Youth
Arch Gen Psychiatry 2007 Sep; 64:(9):1032-1039
http://archpsyc.ama-assn.org/cgi/content/short/64/9/1032

HSL11407
Cassels A.
Lock up your daughters Gardasil is on the loose
Common Ground 2007 Sep
http://commonground.ca/iss/0709194/cg194_cassels.shtml

HSL11414
An S.
Attitude Toward Direct-to-Consumer Advertising and Drug Inquiry Intention: The Moderating Role of Perceived Knowledge.
J Health Commun 2007 Sep; 12:(6):567-80
http://www.informaworld.com/smpp/content?content=10.1080/10810730701508633

HSL11435
Kallen A, Woloshin S, Shu J, Juhl E, Schwartz L.
Direct-to-consumer advertisements for HIV antiretroviral medications: a progress report.
Health Aff (Millwood) 2007 Sep-Oct; 26:(5):1392-8
http://content.healthaffairs.org/cgi/content/abstract/26/5/1392

HSL11477
Vitry A, Mintzes B, Lexchin J
Direct-to-consumer advertising policy in Australia: realism in whose interests?
Internal Medicine Journal 2007 Sep; 37:(9):665–666
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01447.x

HSL11478
Jordens CFC, Kerridge IH, Ankeny RA, MacKenzie FJ, McPhee J.
Reply
Internal Medicine Journal 2007 Sep; 37:(9):666-667
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1445-5994.2007.01448.x

HSL11519
Seston EM, Ashcroft DM, Griffiths CE.
Balancing the benefits and risks of drug treatment: a stated-preference, discrete choice experiment with patients with psoriasis.
Arch Dermatol 2007 Sep; 143:(9):1175-9
http://archderm.ama-assn.org/cgi/content/full/143/9/1175

HSL11557
Ozdemir C, Akdis CA.
Discontinued drugs in 2006: pulmonary-allergy, dermatological, gastrointestinal and arthritis drugs.
Expert Opin Investig Drugs 2007 Sep; 16:(9):1327-44
http://www.expertopin.com/doi/abs/10.1517/13543784.16.9.1327

HSL11558
Feuerstein GZ, Ruffolo RR.
Discontinued drugs in 2006: cardiovascular drugs translational medicine perspective.
Expert Opin Investig Drugs 2007 Sep; 16:(9):1315-26
http://www.expertopin.com/doi/abs/10.1517/13543784.16.9.1315

HSL11564
O'Mara P.
Is Breastfeeding in Trouble?
Mothering Magazine 2007 Sep-Oct
http://www.mothering.com/guest_editors/quiet_place/quiet_place.html

HSL11588
Pena C, Bowsher K, Costello A, De Luca R, Doll S, Li K, Schroeder M, Stevens T.
An overview of FDA medical device regulation as it relates to deep brain stimulation devices.
IEEE Trans Neural Syst Rehabil Eng 2007 Sep; 15:(3):421-4
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17894274

HSL11669
[No authors listed].
Take nutrition claims with a grain of salt. Dietary studies sponsored by the food industry are often biased
Sci Am. 2007 Sep; 297:(3):38, 40
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=PubMed&Cmd=ShowDetailView&TermToSearch=17784619

HSL11687
Ross CJ, Carleton B, Warn DG, Stenton SB, Rassekh SR, Hayden MR.
Genotypic Approaches to Therapy in Children: A National Active Surveillance Network (GATC) to Study the Pharmacogenomics of Severe Adverse Drug Reactions in Children.
Ann N Y Acad Sci 2007 Sep; 1110:177-92
http://www.annalsnyas.org/cgi/content/abstract/1110/1/177

HSL11688
Korczyn AD.
Drug trials in dementia: challenging ethical dilemmas.
Curr Alzheimer Res 2007 Sep; 4:(4):468-72
http://www.ingentaconnect.com/content/ben/car/2007/00000004/00000004/art00018?token=00511708ec5aa35264f65263a3d4f58762f467c405847447b23446c244044765720745d3e3ffaeb23

HSL11726
Castano Riera EJ, Oterino de la Fuente D, Rodriguez Rodrigueza RM.
[The advertising message of drugs advertisements in Spanish medical journals.]
Gac Sanit 2007 Sep-Oct; 21:(5):371-7
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17916300

HSL11738
Canadian Health Services Research Foundation.
Myth: Direct-to-consumer advertising is educational for patients
Myth Busters: A series of essays giving the research evidence behind Canadian health care debates 2007 Sep
http://www.chsrf.ca/mythbusters/pdf/myth27_e.pdf

HSL11749
Weaver DJ, Sorrells-Jones J.
The business case as a strategic tool for change.
J Nurs Adm 2007 Sep; 37:(9):414-9
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00005110-200709000-00008

HSL11750
Taylor-Zapata P, Mattison DR.
Making progress for how medicines are used in children.
Arch Pediatr Adolesc Med 2007 Sep; 161:(9):916
http://archpedi.ama-assn.org/cgi/content/full/161/9/916

HSL11796
Oversteegen L, Rovini H, Belsey MJ.
Respiratory drug market dynamics.
Nat Rev Drug Discov 2007 Sep; 6:(9):695-6
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17907343

HSL11816
Mackie P, Sim F.
A question of rhetoric.
Public Health 2007 Sep; 121:(9):641-2
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B73H6-4P59RYM-1&_user=10&_coverDate=09%2F30%2F2007&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=ead9429b6c0009b972ee01b7c5f15a17

HSL19371
Bras PL, Ricordeau P, Roussille B, Saintoyant V
L'information des médecins généralistes sur le médicament
Inspection générale des affaires sociales 2007 Sep
http://lesrapports.ladocumentationfranca​ise.fr/BRP/074000703/0000.pdf

HSL11884
Bischoff A.
Sounding the Pharma Alarm: Four accounts of the rise of the pharmaceutical industry
Greenspiration 2007 Sep
http://www.greenspiration.org/drug/articles/briarpatch.htm

HSL11913
Cohen-Kohler JC, Esmail LC.
Scientific misconduct, the pharmaceutical industry, and the tragedy of institutions.
Med Law 2007 Sep; 26:(3):431-46
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17970244

HSL11920
Health Council of Canada
Safe and Sound: Optimizing Prescribing Behaviours — Summary of Main Themes and Insights (Report on a Policy Symposium).
Toronto: Health Council of Canada 2007 Sep
http://www.healthcouncilcanada.ca/docs/rpts/2007/pharma/HCC_Symp_Sum_EN_FINAL%20web.pdf

HSL11938
Schachter AD, Ramoni MF, Baio G, Roberts TG Jr, Finkelstein SN.
Economic evaluation of a Bayesian model to predict late-phase success of new chemical entities.
Value Health 2007 Sep-Oct; 10:(5):377-85
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1524-4733.2007.00191.x

HSL11942
Capozzi JD.
Physician advertising: evaluation of a sample advertisement.
J Bone Joint Surg Am 2007 Sep; 89:(9):2089-91
http://www.ejbjs.org/cgi/content/full/89/9/2089

HSL11945
Mrayyan MT, Shishani K, Al-Faouri I.
Rate, causes and reporting of medication errors in Jordan: nurses' perspectives.
J Nurs Manag 2007 Sep; 15:(6):659-70
http://www.blackwell-synergy.com/doi/abs/10.1111/j.1365-2834.2007.00724.x

HSL11978
Lamarque V, Pletan Y.
[The Pharmaceutical Industry and the adverse effects of the drugs].
Ann Pharm Fr 2007 Sep; 65:(5):308-14
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=260&CodeRevue4=APF&Path=REVUE/APF/2007/65/5/ARTICLE11942567985.xml&Locations=

HSL11979
Imbs JL, Welsch M.
[Clinical assessment of drug safety].
Ann Pharm Fr 2007 Sep; 65:(5):298-302
http://www.masson.fr/masson/portal/bookmark?Global=1&Page=18&MenuIdSelected=106&MenuItemSelected=0&MenuSupportSelected=0&CodeProduct4=260&CodeRevue4=APF&Path=REVUE/APF/2007/65/5/ARTICLE11942567983.xml&Locations=

HSL12006
Sikora K.
Cost to the NHS of Roche oncology treatments.
J R Soc Med 2007 Sep; 100:(9):396-7
http://www.jrsm.org/cgi/content/full/100/9/396-b

HSL12007
Miller GM, Stripp R.
A study of western pharmaceuticals contained within samples of Chinese herbal/patent medicines collected from New York City's Chinatown.
Leg Med (Tokyo) 2007 Sep; 9:(5):258-64
http://linkinghub.elsevier.com/retrieve/pii/S1344-6223(07)00057-0

HSL12150
Wilgenbus K, Hill R, Warrander A, Kakkar S, Steiness E, Wessel R.
What pharma wants.
Nat Biotechnol 2007 Sep; 25:(9):967-9
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17977088

HSL12152
Lexchin J.
The secret things belong unto the Lord our God: secrecy in the pharmaceutical arena.
Med Law 2007 Sep; 26:(3):417-30
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17970243

HSL12161
Brownback S.
Eliminating neglected diseases: impact of published paper.
Health Aff (Millwood) 2007 Sep-Oct; 26:(5):1509
http://content.healthaffairs.org/cgi/content/full/26/5/1509

HSL12164
Lowe JA 3rd, Jones P.
Biopharmaceuticals and the future of the pharmaceutical industry.
Curr Opin Drug Discov Devel 2007 Sep; 10:(5):513-4
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17786848

HSL12165
Landau WM.
Pertinacious prescription of practice paradigms: the ethical burden of coercive clinical guidelines.
Curr Neurol Neurosci Rep 2007 Sep; 7:(5):355-8
http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=17764623

HSL12166
Cohen H.
Protecting patients from harm: reduce the risks of high-alert drugs.
Nursing 2007 Sep; 37:(9):49-55
http://meta.wkhealth.com/pt/pt-core/template-journal/lwwgateway/media/landingpage.htm?an=00152193-200709000-00040

HSL12199
Fowler C.
Contentious issue of funding and the pharmaceutical industry--should service user groups take the big pharma shilling, and and what are the costs if they do?
Ment Health Today 2007 Sep; :40:
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=ShowDetailView&TermToSearch=17933061

HSL12200
Chen JT, Summers KH.
Pharmaceutical manufacturer prescription assistance programs: are they worth it?
J Manag Care Pharm 2007 Sep; 13:(7):611-3
http://www.amcp.org/data/jmcp/JMCPMaga_Sept%2007_611-613.pdf

HSL12202
Wick C, Egger M, Trelle S, Jüni P, Fey MF.
The characteristics of unsolicited clinical oncology literature provided by pharmaceutical industry.
Ann Oncol 2007 Sep; 18:(9):1580-2
http://annonc.oxfordjournals.org/cgi/content/full/18/9/1580

HSL12203
Coleman MP.
Not credible: a subversion of science by the pharmaceutical industry: Commentary on a global comparison regarding patient access to cancer drugs
Ann Oncol 2007 Sep; 18:(Suppl 3):175
http://annonc.oxfordjournals.org/cgi/content/full/18/9/1433

HSL12206
Volkers AC, Heerdink ER, van Dijk L.
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Pharmacoepidemiol Drug Saf 2007 Sep; 16:(9):1054-62
http://www3.interscience.wiley.com/cgi-bin/abstract/114277040/ABSTRACT?CRETRY=1&SRETRY=0

HSL12207
Dean AJ, Hendy A, McGuire T.
Antidepressants in children and adolescents--changes in utilisation after safety warnings.
Pharmacoepidemiol Drug Saf 2007 Sep; 16:(9):1048-53
http://www3.interscience.wiley.com/cgi-bin/abstract/114210439/ABSTRACT

HSL12253
Klotz U.
The bridging function of clinical pharmacology.
Eur J Clin Pharmacol 2007 Sep; 63:(9):817-9
http://www.springerlink.com/content/y0h8406051668611/

HSL12377
Kale SA, Barkin RL.
Tactics of the physician-controlled counter--detail and the imminent risk of not changing pharma's detail relationship with physicians.
J Opioid Manag 2007 Sep-Oct; 3:(5):239-41
http://www.ncbi.nlm.nih.gov/pubmed/18181376

HSL12388
Goldsmith D, Kuhlmann M, Covic A.
Through the looking glass: the protein science of biosimilars.
Clin Exp Nephrol 2007 Sep; 11:(3):191-5
http://www.ncbi.nlm.nih.gov/pubmed/17891344

HSL12403
Holleman F, Gale EA.
Nice insulins, pity about the evidence.
Diabetologia 2007 Sep; 50:(9):1783-90
http://www.springerlink.com/content/qt85387u68h1x487/

HSL12404
Halban PA.
The innovative medicines initiative (IMI): a shot in the arm for European diabetes research?
Diabetologia 2007 Sep; 50:(9):1791-4
http://www.springerlink.com/content/e247801475621302/

HSL12449
Schwartz LM, Woloshin S, Welch HG.
The drug facts box: providing consumers with simple tabular data on drug benefit and harm.
Med Decis Making 2007 Sep-Oct; 27:(5):655-62
http://mdm.sagepub.com/cgi/reprint/27/5/655

HSL12499
Solomon LM, Sieczkiewicz GJ.
Impact of the US Patent System on the promise of personalized medicine.
Gend Med 2007 Sep; 4:(3):187-92
http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B7MDM-4R5PGRY-2&_user=10&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=b3eee273e27774ae1c9836eb5c394027

HSL12586
Massol J, Puech A, Boissel JP.
How to anticipate the assessment of the public health benefit of new medicines?
Therapie 2007 Sep-Oct; 62:(5):427-35
http://www.journal-therapie.org/index.php?option=article&access=doi&doi=10.2515/therapie:2007071

HSL12603
Brieger WR, Salami KK, Oshiname FO.
Perceptions of drug color among drug sellers and consumers in rural southwestern Nigeria.
Res Social Adm Pharm 2007 Sep; 3:(3):303-19
http://www.ncbi.nlm.nih.gov/pubmed/17945160

HSL12666
Wolf MS, Bailey SC.
Improving prescription drug labeling.
N C Med J 2007 Sep-Oct; 68:(5):340-2
http://www.ncbi.nlm.nih.gov/pubmed/18183755?dopt=Abstract

HSL12679
Martín-Aranda P, Vázquez I, Rodríguez de Cossío A.
[Interns and the pharmaceutical industry].
Aten Primaria. 2007 Sep; 39:(9):510-1
http://www.doyma.es/cgi-bin/wdbcgi.exe/doyma/mrevista.fulltext?pident=13109506

HSL12754
Van Way CW 3rd.
The new relationship between physicians & industry.
Mo Med 2007 Sep-Oct; 104:(5):375-7
http://www.ncbi.nlm.nih.gov/pubmed/18018517

HSL13036
Jacob R.
It is time to wash the linen.
Natl Med J India 2007 Sep-Oct; 20:(5):272
http://www.ncbi.nlm.nih.gov/pubmed/18254532

HSL13042
Sevillano D, Ramos C.
[The birth of the greatest invention of the 20th century].
Rev Esp Quimioter 2007 Sep; 20:(3):354-8
http://www.ncbi.nlm.nih.gov/pubmed/18080034

HSL13501
Akande TM, Aderibigbe SA.
Influence of drug promotion on prescribing habits of doctors in a teaching hospital.
Afr J Med Med Sci. 2007 Sep; 36:(3):207-11

HSL14853
Borges de Melo E, Teixeira JJ, Mânica GC.
[Description of attempts to obtain approval for selling medications at ordinary Brazilian establishments after the introduction of the Real Economic Stabilization Plan].
Cien Saude Colet. 2007 Sep-Oct; 12:(5):1333-9
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1413-81232007000500031&lng=en&nrm=iso&tlng=en

HSL11346
Sanofi-Aventis faces sexual discrimination lawsuit in the USA
Pharma Times 2007 Aug 31
http://www.pharmatimes.com/WorldNews/ViewArticle.aspx?id=11641

HSL11347
Grogan K.
Australia fast becoming a centre for innovative R&D
Pharma Times 2007 Aug 31
http://www.pharmatimes.com/WorldNews/ViewArticle.aspx?id=11642

HSL11348
Johnson S.
Did Pfizer's marketing fizzle with Exubera?
San Jose Mercury News 2007 Aug 31
http://www.mercurynews.com/business/ci_6767521?nclick_check=1

HSL11352
Xenical ad ban upheld
Pharmacy Daily (Australia) - registration required 2007 Aug 31
http://www.pharmacydaily.com.au

HSL11353
Kaufman M, Lee C.
HHS Toned Down Breast-Feeding Ads
Washington Post 2007 Aug 31
http://www.washingtonpost.com/wp-dyn/content/article/2007/08/30/AR2007083002198_pf.html

HSL11401
Toutant C.
Schering-Plough Defends Suits Over Marketing of 'Off-Label' Drug Uses
New Jersey Law Journal 2007 Aug 31
http://www.law.com/jsp/article.jsp?id=1188464549972

HSL11422
PMCPA defends FT claims
PMLive.com 2007 Aug 31
http://www.pmlive.com/index.cfm?showArticle=1&ArticleID=5845

HSL11408
Pharmaceuticals reps in Nigeria defend Pfizer's credibility
Agence France-Presse 2007 Aug 30
http://news.yahoo.com/s/afp/20070830/ts_alt_afp/nigeriaushealthpfizer

HSL11497
Pfizer Proves It Can Do More with Lipitor - Protecting Vital Access to Patients at the Heart of Winning Managed Care Strategy
Business Wire 2007 Aug 30
http://pharmalive.com/news/index.cfm?articleID=471340&categoryid=43

HSL11338
Woodhead M.
Orthodox medicine eclipsed
6minutes (Australia) 2007 Aug 29
http://www.6minutes.com.au/dirplus/images/6minutes/newspluspharma/29_08_2007.pdf

HSL11341
Pharma behaving badly
FT.com 2007 Aug 29
http://biz.yahoo.com/ft/070829/fto082920070556310863.html?.v=1

HSL11342
Nagle M.
GSK drug could prove unlikely saviour for Vioxx
DrugResearcher.com 2007 Aug 29
http://www.in-pharmatechnologist.com/news/ng.asp?n=79312-merck-co-glaxosmithkline-university-of-connecticut-ppar-delta-vioxx

HSL11354
IMS Health, Wolters Kluwer Health and Verispan Challenge State Laws Restricting Access to Critical Healthcare Information
PharmaLive 2007 Aug 29
http://www.pharmalive.com/News/index.cfm?articleid=470977&categoryid=10

HSL14756
Abbott Laboratories Deletes Safety Concerns From Web
Patients Not Patents 2007 Aug 29

HSL11302
Drug firms go direct in UK
Pharmacy Daily (Australia) - registration required 2007 Aug 28
http://www.pharmacydaily.com.au

HSL11333
Practicing What They Preach: GSK Announces Employee Wellness Initiative
PRNewswire-FirstCall 2007 Aug 28
http://biz.yahoo.com/prnews/070828/netu023.html?.v=20

HSL11336
Pagnamenta R.
Pharmaceutical groups turn to home delivery
The Times (London, UK) 2007 Aug 28
http://business.timesonline.co.uk/tol/business/industry_sectors/health/article2337383.ece

HSL11337
Multicultural Marketing of Health and Wellness to Women. The Trend Report Examines Ethnic & Demographic Differences in Health-care-related Opinions and Behaviors
PharmaLive 2007 Aug 28
http://pharmalive.com/news/index.cfm?articleID=470312&categoryid=9&newsletter=1

HSL11343
Ganguli I.
Is Your Doctor in Denial?
The Washington Post 2007 Aug 28HE04
http://www.washingtonpost.com/wp-dyn/content/article/2007/08/24/AR2007082401714_pf.html

HSL11379
Mansfield P.
Pharma pays the piper: will Roche call Kidney Health Australia’s tune?
Crikey 2007 Aug 28
http://www.crikey.com.au/Politics/20070827-Pharma-pays-the-piper-Will-Roche-call-Kidney-Health-Australias-tune.html

HSL11380
Rosenberg M.
What's Missing on Your FDA Drug Warning Label: Corporate Influence over the Safety Process
AlterNet 2007 Aug 28
http://www.alternet.org/healthwellness/60973

HSL11248
Gulli C.
Our girls are not guinea pigs
Maclean's Magazine 2007 Aug 27
http://www.macleans.ca/science/health/article.jsp?content=20070827_108312_108312&page=1

HSL11335
Nahin RL, Dahlhamer JM, Taylor BL, Barnes , Stussman BJ, Simile CM, Blackman MR, Chesney MA, Jackson M, Miller H, McFann KK.
Health behaviors and risk factors in those who use complementary and alternative medicine
BMC Public Health 2007 Aug 27; 7:217
http://www.biomedcentral.com/1471-2458/7/217/abstract

HSL11382
Cox S.
Toxic Waste Exposure Is the High Price Developing Countries Pay to Produce Our Medicine
AlterNet 2007 Aug 27
http://www.alternet.org/story/59986/

HSL11406
Olson J.
Drug makers step up giving to Minnesota psychiatrists
Pioneer Press 2007 Aug 27
http://www.twincities.com/allheadlines/ci_6728068?nclick_check=1

HSL11304
Lakhani N.
Pharmageddon: the prescription pill epidemic
The Independent 2007 Aug 26
http://news.independent.co.uk/health/article2896181.ece

HSL11344
Shields J.
Mentally ill children
Background Briefing, ABC (Australia) 2007 Aug 26
http://www.abc.net.au/rn/backgroundbriefing/stories/2007/2012718.htm

HSL11663
Gornall J.
Hyperactivity in children: the Gillberg affair
BMJ 2007 Aug 25; 335:(7616):370
http://www.bmj.com/cgi/content/short/335/7616/370?etoc

HSL11664
Burton B.
Australian drugs regulator cancels registration of COX 2 inhibitor
BMJ 2007 Aug 25; 335:(7616):363
http://www.bmj.com/cgi/content/short/335/7616/363-a?etoc

HSL11665
Chalmers I.
The Alzheimer's Society, drug manufacturers, and public trust
BMJ 2007 Aug 25; 335:(7616):400
http://www.bmj.com/cgi/content/short/335/7616/400?etoc

HSL11301
Breast cancer decline attributed to drop in HRT
Reuters Health 2007 Aug 24
http://www.reuters.com/article/healthNews/idUSROB47731420070824

HSL11307
Smith A.
For Big Pharma, drugs are a hard global sell
CNNMoney.com 2007 Aug 24
http://money.cnn.com/2007/08/20/news/companies/drug_launch/index.htm?source=yahoo_quote

HSL11328
Elser C.
Novartis Tells Prexige Patients to Get Liver Tests
Bloomberg News 2007 Aug 24
http://www.bloomberg.com/apps/news?pid=20601202&sid=aGLKlHIdSNPc&refer=healthcare

HSL11329
Viksjo J.
007 Secret Weapons of Drug Firms
Morningstar.com 2007 Aug 24
http://biz.yahoo.com/ms/070824/203879.html?.v=1

HSL11332
GSK offers Tykerb
Pharmacy Daily (Australia) - registration required 2007 Aug 24
http://www.pharmacydaily.com.au

Page 52 of 144 pages ‹ First  < 50 51 52 53 54 >  Last ›

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.







As an advertising man, I can assure you that advertising which does not work does not continue to run. If experience did not show beyond doubt that the great majority of doctors are splendidly responsive to current [prescription drug] advertising, new techniques would be devised in short order. And if, indeed, candor, accuracy, scientific completeness, and a permanent ban on cartoons came to be essential for the successful promotion of [prescription] drugs, advertising would have no choice but to comply.
- Pierre R. Garai (advertising executive) 1963